BACKGROUND: Breast cancer is the second leading cause of cancer deaths in US women. We evaluated two novel compounds, piperidinyl-diethylstilbestrol (DES) and pyrrolidinyl-diethylstilbestrol (DES) for cytotoxicity against brine shrimp larvae, MCF-7 and rat normal liver cells. MATERIALS AND METHODS: In vivo cytotoxicity was evaluated against shrimp larvae for 24 h, while in vitro cell toxicity was evaluated by dye binding crystal-violet method after 48 h. The role of these compounds on different phases of the cell cycle was assessed by flow cytometry. RESULTS: In shrimp assay, piperidinyl-DES and pyrrolidinyl-DES were potent with 50% effective dose (ED(50)) values of 7.9+/-0.38 and 15.6+/-1.3 microM, respectively. In MCF-7 and normal liver cells, the 50% lethal concentration (LC(50)) values were 19.7+/-0.95, 17.6+/-0.4 microM and 35.1 and >50 microM, respectively. Cell cycle analyses indicated that MCF-7 cells were arrested at the G(0)/G(1) stage with these compounds. CONCLUSION: The results indicate that pyrrolidinyl-DES possesses highly selective, potent anticancer activity.
BACKGROUND:Breast cancer is the second leading cause of cancer deaths in US women. We evaluated two novel compounds, piperidinyl-diethylstilbestrol (DES) and pyrrolidinyl-diethylstilbestrol (DES) for cytotoxicity against brine shrimp larvae, MCF-7 and rat normal liver cells. MATERIALS AND METHODS: In vivo cytotoxicity was evaluated against shrimp larvae for 24 h, while in vitro cell toxicity was evaluated by dye binding crystal-violet method after 48 h. The role of these compounds on different phases of the cell cycle was assessed by flow cytometry. RESULTS: In shrimp assay, piperidinyl-DES and pyrrolidinyl-DES were potent with 50% effective dose (ED(50)) values of 7.9+/-0.38 and 15.6+/-1.3 microM, respectively. In MCF-7 and normal liver cells, the 50% lethal concentration (LC(50)) values were 19.7+/-0.95, 17.6+/-0.4 microM and 35.1 and >50 microM, respectively. Cell cycle analyses indicated that MCF-7 cells were arrested at the G(0)/G(1) stage with these compounds. CONCLUSION: The results indicate that pyrrolidinyl-DES possesses highly selective, potent anticancer activity.
Authors: M Couladis; R B Badisa; P Baziou; S K Chaudhuri; E Pilarinou; E Verykokidou; C Harvala Journal: Phytother Res Date: 2002-12 Impact factor: 5.878
Authors: Veera L D Badisa; Lekan M Latinwo; Caroline O Odewumi; Christopher O Ikediobi; Ramesh B Badisa; Alexis Brooks-Walter; Ayuk-Takem T Lambert; Jude Nwoga Journal: Int J Mol Med Date: 2008-08 Impact factor: 4.101
Authors: Caroline O Odewumi; Rebecca Buggs; Veera L D Badisa; Lekan M Latinwo; Ramesh B Badisa; Christopher O Ikediobi; Selina F Darling-Reed; Marcia A Owens Journal: Toxicol In Vitro Date: 2011-09-03 Impact factor: 3.500
Authors: Caroline O Odewumi; Veera L D Badisa; Uyen T Le; Lekan M Latinwo; Christopher O Ikediobi; Ramesh B Badisa; Selina F Darling-Reed Journal: Int J Mol Med Date: 2010-12-01 Impact factor: 4.101
Authors: Larry H Russell; Elizabeth Mazzio; Ramesh B Badisa; Zhi-Ping Zhu; Maryam Agharahimi; Donna J Millington; Carl B Goodman Journal: Anticancer Res Date: 2011-11 Impact factor: 2.480
Authors: Fernanda F Campos; Jonas P Ramos; Djalma M DE Oliveira; Tania M A Alves; Elaine M DE Souza-Fagundes; Carlos L Zani; Fabio C Sampaio; Attilio Converti; Betania B Cota Journal: J Biosci Date: 2017-12 Impact factor: 1.826
Authors: Musiliyu A Musa; Veera L D Badisa; Lekan M Latinwo; Caroline Waryoba; Ngozi Ugochukwu Journal: Anticancer Res Date: 2010-11 Impact factor: 2.480